Learning from Coca-Cola
When it comes to expanding medical supply chains in the developing world, there is much to be learned from Coca-Cola’s global-scale production and distribution model, and there is much to be borrowed. There is also much that is impossible to replicate.
Over the past century, new technologies, innovation in delivery models, and increased government support have drastically transformed the health of human populations. Most people living in the developed world now live longer and healthier lives than ever before. Yet for the 1.29 billion people living on less than $1.25 per day, quality health care remains out of reach. The World Health Organization estimates that every year more than 7.6 million children under the age of 5 die and more than 1.7...
Want more? Sorry, the full text of this article is only available to subscribers. Subscribe now.
Already a subscriber? Please log in by entering your email address and password into the red login box at the top-right corner of this page.
Need to register for your premium online access, which is included with your paid subscription? Register here.
Research shows that healthcare social enterprises are segmenting the BOP and leaving the bottom 50 percent of consumers behind.
Solnechny Mir (Our Sunny World) is a Russian rehabilitation center that hosts more than 250 children and their families each week.
A community-based program in rural Kentucky uses face-to-face social networks to promote wellness.
The knowledge, skill, and compassion of the health care community can help stop modern slavery.
Getting promising drug discoveries out of university labs and into the drug pipeline is more difficult than it should be.
Advance market commitments can help solve global development problems impaired by market failure.
Connecting information, applications, data, and people—a report from the Stanford 2013 Healthcare Innovation Summit.
Lessons for entrepreneurs abound in the new biography on Molly Melching’s work.
